Guest guest Posted January 30, 2004 Report Share Posted January 30, 2004 Worsening of obstructive sleep apnoeas in a patient with rheumatoid arthritis treated with anti-tumor necrosis factor Respiratory Medicine Volume 98, Issue 2 , February 2004, Pages 123-125 http://www.sciencedirect.com/ Abstract We report on a case of an adult patient treated for rheumatoid arthritis with infliximab, a chimerical monoclonal antibody to TNF alpha. Apart from this, the patient also showed clinical signs of obstructive sleep apnea syndrome that was confirmed by polysomnographic study. After infliximab treatment, additional sleep studies revealed an increase in the number of apneic events and SaO2 dips suggesting that TNF alpha plays an important role in the pathophysiology of sleep apnea. Thus, clinical recognition of sleep disordered breathing should be taken into account when rheumatoid arthritis patients are to be treated with infliximab. Zamarrón Corresponding Author, a, Francisco Maceirasb, Gonzáleza and J. Gómez-Reinob a Sleep Unit, Division of Respiratory Medicine, Department of Medicine of the Hospital Clinico Universitario and Santiago Medical School, Santiago, Spain b Rheumatolology Service, Department of Medicine of the Hospital Clinico Universitario and Santiago Medical School, Santiago, Spain Servicio de Neumología, Hospital Clínico Universitario de Santiago, C/Choupana s/n, Santiago de Compostela 15706, Spain Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.